Virginia Commonwealth University School of Medicine (mastocytosis) — Richmond, Virginia

Virginia Commonwealth University School of Medicine (mastocytosis) is a clinical research site located in Richmond, Virginia, United States 23219.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Virginia Commonwealth University School of Medicine (mastocytosis) has participated in 1 clinical trials.

Therapeutic areas: Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers.

Sponsors: Deciphera Pharmaceuticals, LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Virginia Commonwealth University School of Medicine (mastocytosis)?

Virginia Commonwealth University School of Medicine (mastocytosis) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Virginia Commonwealth University School of Medicine (mastocytosis) conducted?

Virginia Commonwealth University School of Medicine (mastocytosis) has 1 clinical trials on record. Their work covers Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers.

Is Virginia Commonwealth University School of Medicine (mastocytosis) accredited by Crixeo Health?

Virginia Commonwealth University School of Medicine (mastocytosis) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Virginia Commonwealth University School of Medicine (mastocytosis)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.